| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2019-07-16 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 28.2% | EDGAR |
| SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | Dexxon Holdings Ltd. | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | SVF Investments (UK) Ltd | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-07-12 | QVT Financial LP | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-14 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 4,335,746 | 7.8% | EDGAR |
| SC 13G | 2019-02-14 | EcoR1 Capital, LLC | Arbutus Biopharma Corp | 3,281,502 | 5.9% | EDGAR |
| SC 13G/A | 2019-02-08 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 4,040,900 | 7.3% | EDGAR |
| SC 13D/A | 2019-01-03 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 28.9% | EDGAR |
| SC 13D/A | 2018-04-23 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-04-12 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-03-16 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13G/A | 2018-02-27 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 4,000,400 | 7.3% | EDGAR |
| SC 13D/A | 2018-02-14 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13G/A | 2018-02-14 | RTW INVESTMENTS, LP | Arbutus Biopharma Corp | 5,151,615 | 9.4% | EDGAR |
| SC 13D/A | 2018-01-16 | VIKING GLOBAL INVESTORS LP | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-01-16 | Machado Patrick | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-01-16 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-01-16 | Lo Andrew | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |
| SC 13D/A | 2018-01-16 | Dexxon Holdings Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.1% | EDGAR |